Alkermes
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
CEORichard F. Pops
CEORichard F. Pops
Employees2,100
Employees2,100
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2011
Founded2011
Employees2,100
Employees2,100
ALKS Key Statistics
Market cap4.04B
Market cap4.04B
Price-Earnings ratio9.47
Price-Earnings ratio9.47
Dividend yield—
Dividend yield—
Average volume1.80M
Average volume1.80M
High today$23.99
High today$23.99
Low today$23.39
Low today$23.39
Open price$23.87
Open price$23.87
Volume1.93M
Volume1.93M
52 Week high$33.17
52 Week high$33.17
52 Week low$21.66
52 Week low$21.66
ALKS News
Simply Wall St 12h
Alkermes First Quarter 2024 Earnings: Misses Expectations - Simply Wall StAlkermes ( ) First Quarter 2024 Results Key Financial Results Revenue: US$350.4m (up 22% from 1Q 2023). Net income: US$38.9m (up from US$41.8m loss in 1Q 202...
TipRanks 1d
Alkermes reports Q1 adjusted EPS 43c, consensus 58c - TipRanks.com - TipRanksReports Q1 revenue $350.4M, consensus $360.26M. “The first quarter of 2024 marks our first full quarter as a profitable, pure-play neuroscience company. During...
Yahoo Finance 2d
Alkermes Q1 Earnings and Revenues Miss Estimates - Yahoo FinanceAlkermes (ALKS) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.01...
Analyst ratings
54%
of 13 ratingsBuy
53.8%
Hold
38.5%
Sell
7.7%
More ALKS News
TipRanks 2d
Alkermes backs FY24 financial outlookAlkermes reiterates its financial expectations for 2024, as set forth in its press release dated Feb. 15, 2024. Published first on TheFly – the ultimate source...